Artificial intelligence-driven pathomics in hepatocellular carcinoma: current developments, challenges and perspectives
Abstract Hepatocellular carcinoma (HCC) is a highly malignant tumor with elevated incidence and mortality rates globally. Its complex etiology and pronounced heterogeneity present significant challenges in diagnosis and treatment. Recent advancements in artificial intelligence (AI) have demonstrated...
Saved in:
| Main Authors: | Wei Ding, Jinxing Zhang, Zhicheng Jin, Hongjin Hua, Qingquan Zu, Shudong Yang, Weidong Wang, Sheng Liu, Haifeng Zhou, Haibin Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03254-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting overall survival in hepatocellular carcinoma patients via a combined MRI radiomics and pathomics signature
by: Lijuan Feng, et al.
Published: (2025-01-01) -
Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
by: Valentina Brancato, et al.
Published: (2024-12-01) -
Unveiling key pathomic features for automated diagnosis and Gleason grade estimation in prostate cancer
by: Valentina Brancato, et al.
Published: (2025-07-01) -
Advances in the use of Radiomics and Pathomics for predicting the efficacy of neoadjuvant therapy in tumors
by: Jiayi Wang, et al.
Published: (2025-08-01) -
Construction and validation of a prognostic nomogram model integrating machine learning-pathomics and clinical features in IDH-wildtype glioblastoma
by: Yaomin Li, et al.
Published: (2025-06-01)